Skip to content
PressReach
SEARCH
Investing
Featured
Market
Biotech
Oil & Gas
Mining
Gaming
Tech
Crypto
More
Health
Entertainment
Real Estate
Cannabis
ESG
Financial
Food & Beverage
Industrials
Travel & Hospitality
Trading Tips
Investing Videos
Search
SEARCH FOR AN ARTICLE
Search
Search
Investing
Featured
Market
Biotech
Oil & Gas
Mining
Gaming
Tech
Crypto
More
Health
Entertainment
Real Estate
Cannabis
ESG
Financial
Food & Beverage
Industrials
Travel & Hospitality
Trading Tips
Investing Videos
PressReach
SEARCH
Home
Novo Nordisk A/S
Novo Nordisk A/S
Investing News
Novo Study: Ozempic Reduces Kidney Disease Death Risk
May 24, 2024
Investing News
Novo Nordisk Pressured by Amgen’s Obesity Drug Advancements
May 3, 2024
«
1
2
LATEST NEWS
Investing News
Revolut Reports Record Profits in 2025
Investing News
Salesforce’s $25B Debt Move for Stock Buyback
Investing News
FedEx Q3 2026 Earnings Insights
Investing News
Alibaba’s AI Investments Shine
Investing News
Micron’s Q2 Earnings Exceed Expectations
Search
Novo Nordisk A/S
May 24, 2024
May 3, 2024
